Niosomal Bupropion: Exploring Therapeutic Frontiers through Behavioral Profiling

• Main Authors: Karthick Harini (Author), Suliman Yousef Alomar (Author), Mohammed Vajagathali (Author), Salim Manoharadas (Author), Anbazhagan Thirumalai (Author), Koyeli Girigoswami (Author), Agnishwar Girigoswami (Author)
• Format: Book
• Published: MDPI AG, 2024-03-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Bupropion (Bup) belongs to the norepinephrine-dopamine reuptake inhibitor (NDRI) class and it is the only FDA-approved drug of its class for the treatment of major depressive disorder (MDD), sold under the name of Wellbutrin. Although bupropion is effective in suppressing the symptoms, its regular u...